MICHELLE LINDSEY: Open Payments
NPI 1295089217 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 18 payments from 9 companies in 2025. Trend: 2023 $197 · 2024 $289 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| Novo Nordisk Inc | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: QULIPTA, UBRELVY, Ozempic, XIFAXAN, ZORYVE, Kerendia, FREESTYLE LIBRE, Rybelsus.
Industry payments across LA — which companies pay providers there.
